Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
GLP-1RAs reduce risks of neurocognitive, substance use, cardiovascular and respiratory disorders, but increase risks of gastrointestinal issues, hypotension and pancreatitis
Klaman, L
For those cost-conscious or paying out of pocket, compounding pharmacies and telehealth providers like Daytryp can often provide tirzepatide at a lower cost than brand-name Mounjaro pens
What Clinical Results Show About Retatrutide In December 2025, Eli Lilly announced positive results from the Phase 3 TRIUMPH-4 trial
US$ 23.26
US$ 20.83
US$ 21.34
US$ 21.32
US$ 22.55
US$ 25.57
US$ 28.75
